Clinical cardiovascular adverse events reported post-COVID-19 vaccination: are they a real risk?

D Hana, K Patel, S Roman, B Gattas, S Sofka - Current Problems in …, 2022 - Elsevier
Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …
被引用次数：27 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?

D Hana, K Patel, S Roman, B Gattas… - Current Problems in …, 2022 - ncbi.nlm.nih.gov
Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …
[PDF] researchgate.net

[PDF][PDF] Clinical Cardiovascular Adverse Events Reported Post COVID-19 Vaccination: Are they a real risk?

D Hana, K Patel, S Roman, B Gattas, S Sofka - 1921 - researchgate.net
Given the urgent need to control the spread of the novel COVID-19 virus, thirteen vaccines
have been approved for emergency use before completing all three phases of the clinical …

Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?

D Hana, K Patel, S Roman, B Gattas… - Current Problems in …, 2021 - europepmc.org
Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …

Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?

D Hana, K Patel, S Roman… - Current problems in …, 2022 - pubmed.ncbi.nlm.nih.gov
Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have
been approved for emergency use before completing all 3 phases of the clinical trials …